Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Hematopoietic Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma Harboring a 8q24/ MYC Rearrangement: A Retrospective Registry Study from the Japan Society for Hematopoietic Cell Transplantation

Tsutomu Takahashi, MD PhD, Ritsuro Suzuki, MD PhD, Koji Izutsu, MD PhD, Hideyuki Nakazawa, MD PhD, Sachiko Suzuki, MD PhD, Junya Kuroda, MD PhD, Katsuji Kaida, MD PhD, Hitoshi Ohno, MD PhD, Takahiro Fukuda, MD, Tatsuo Ichinohe, MD PhD, Yoshiko Atsuta, MD PhD, Junji Suzumiya, MD PhD

Blood (2016) 128 (22): 1868.

https://doi.org/10.1182/blood.V128.22.1868.1868

Published: 2016

Journal Articles

FDG-PET/CT Early After 90Y-Ibritumomab Tiuxetan Therapy Predicts Outcome in Relapsed or Refractory Indolent B-Cell Lymphoma

Masaya Okada, MD, PhD, Yoshihiro Fujimori, MD, PhD, Naohiko Oku, MD, PhD, Akira Tamekane, MD, PhD, Toshiro Takafuta, MD, PhD, Toshiyuki Nakajima, MD, Tazuko Tokugawa, MD, Akihiro Sawada, MD, Shin-ichi Ishii, MD, Katsuji Kaida, MD, Kazuhiro Ikegame, MD, PhD, Toshihiro Soma, MD, PhD, Hiroyasu Ogawa, MD, PhD

Blood (2012) 120 (21): 3648.

https://doi.org/10.1182/blood.V120.21.3648.3648

Published: 2012

Journal Articles

A Novel Regimen of Unmanipulated HLA-Haploidentical Transplantation Using a Small Dose of Anti-T-Lymphocyte Globulin for Patients in High Tumor Burden

Shinichi Ishii, MD, Kazuhiro Ikegame, MD, PhD, Katsuji Kaida, MD, Satoshi Yoshihara, MD, PhD, Masaya Okada, MD, PhD, Ruri Kato, MD, Takayuki Inoue, MD, Hiroya Tamaki, MD, PhD, Yoshihiro Fujimori, MD, PhD, Toshihiro Soma, Hiroyasu Ogawa, MD, PhD

Blood (2012) 120 (21): 4203.

https://doi.org/10.1182/blood.V120.21.4203.4203

Published: 2012

Journal Articles

Unmanipulated HLA-Haploidentical (2-3 antigen-mismatched) Stem Cell Transplantation Using Myeloablative or Reduced-Intensity Preconditioning Regimen,

Katsuji Kaida, MD, Kazuhiro Ikegame, MD, PhD, Satoshi Yoshihara, MD, PhD, Kyoko Taniguchi, MD, Shinichi Ishii, MD, Ruri Kato, MD, Takayuki Inoue, MD, Masaya Okada, MD, PhD, Hiroya Tamaki, MD, PhD, Tatsuya Fujioka, MD, PhD, Toshihiro Soma, MD, PhD, Hiroyasu Ogawa, MD, PhD

Blood (2011) 118 (21): 4117.

https://doi.org/10.1182/blood.V118.21.4117.4117

Published: 2011

Journal Articles

Mechanism of Marked Reduction In the Severity of Graft-Versus-Host Disease by Reduced-Intensity Conditioning In Murine MHC-Haploidentical BMT Model

Takayuki Inoue, Kazuhiro Ikegame, Satoshi Yoshihara, Katsuji Kaida, Kyoko Taniguchi, Hiroya Tamaki, Tatsuya Fujioka, Masaya Okada, Ruri Kato, Yoko Yamamoto, Toshihiro Soma, Hiroyasu Ogawa

Blood (2010) 116 (21): 4707.

https://doi.org/10.1182/blood.V116.21.4707.4707

Published: 2010

NARROW

Hematopoietic Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma Harboring a 8q24/ MYC Rearrangement: A Retrospective Registry Study from the Japan Society for Hematopoietic Cell Transplantation

FDG-PET/CT Early After 90Y-Ibritumomab Tiuxetan Therapy Predicts Outcome in Relapsed or Refractory Indolent B-Cell Lymphoma

A Novel Regimen of Unmanipulated HLA-Haploidentical Transplantation Using a Small Dose of Anti-T-Lymphocyte Globulin for Patients in High Tumor Burden

Unmanipulated HLA-Haploidentical (2-3 antigen-mismatched) Stem Cell Transplantation Using Myeloablative or Reduced-Intensity Preconditioning Regimen,

Mechanism of Marked Reduction In the Severity of Graft-Versus-Host Disease by Reduced-Intensity Conditioning In Murine MHC-Haploidentical BMT Model

Email alerts

ASH Publications

American Society of Hematology

Hematopoietic Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma Harboring a 8q24/ MYC Rearrangement: A Retrospective Registry Study from the Japan Society for Hematopoietic Cell Transplantation

FDG-PET/CT Early After 90Y-Ibritumomab Tiuxetan Therapy Predicts Outcome in Relapsed or Refractory Indolent B-Cell Lymphoma

A Novel Regimen of Unmanipulated HLA-Haploidentical Transplantation Using a Small Dose of Anti-T-Lymphocyte Globulin for Patients in High Tumor Burden

Unmanipulated HLA-Haploidentical (2-3 antigen-mismatched) Stem Cell Transplantation Using Myeloablative or Reduced-Intensity Preconditioning Regimen,

Mechanism of Marked Reduction In the Severity of Graft-Versus-Host Disease by Reduced-Intensity Conditioning In Murine MHC-Haploidentical BMT Model

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only